1. Home
  2. ICUI vs BRC Comparison

ICUI vs BRC Comparison

Compare ICUI & BRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • BRC
  • Stock Information
  • Founded
  • ICUI 1984
  • BRC 1914
  • Country
  • ICUI United States
  • BRC United States
  • Employees
  • ICUI N/A
  • BRC N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • BRC Miscellaneous manufacturing industries
  • Sector
  • ICUI Health Care
  • BRC Consumer Discretionary
  • Exchange
  • ICUI Nasdaq
  • BRC Nasdaq
  • Market Cap
  • ICUI 3.0B
  • BRC 3.4B
  • IPO Year
  • ICUI 1992
  • BRC 1984
  • Fundamental
  • Price
  • ICUI $128.18
  • BRC $76.56
  • Analyst Decision
  • ICUI Buy
  • BRC
  • Analyst Count
  • ICUI 6
  • BRC 0
  • Target Price
  • ICUI $185.00
  • BRC N/A
  • AVG Volume (30 Days)
  • ICUI 371.2K
  • BRC 134.7K
  • Earning Date
  • ICUI 08-07-2025
  • BRC 09-05-2025
  • Dividend Yield
  • ICUI N/A
  • BRC 1.30%
  • EPS Growth
  • ICUI N/A
  • BRC 3.35
  • EPS
  • ICUI N/A
  • BRC 4.03
  • Revenue
  • ICUI $2,372,504,000.00
  • BRC $1,459,732,000.00
  • Revenue This Year
  • ICUI N/A
  • BRC $13.02
  • Revenue Next Year
  • ICUI N/A
  • BRC $3.76
  • P/E Ratio
  • ICUI N/A
  • BRC $18.36
  • Revenue Growth
  • ICUI 2.96
  • BRC 8.62
  • 52 Week Low
  • ICUI $107.00
  • BRC $62.70
  • 52 Week High
  • ICUI $196.26
  • BRC $77.68
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 55.51
  • BRC 73.85
  • Support Level
  • ICUI $120.95
  • BRC $72.60
  • Resistance Level
  • ICUI $125.02
  • BRC $73.57
  • Average True Range (ATR)
  • ICUI 5.30
  • BRC 1.24
  • MACD
  • ICUI 1.12
  • BRC 0.39
  • Stochastic Oscillator
  • ICUI 82.93
  • BRC 96.14

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

Share on Social Networks: